Literature DB >> 25462584

Effect of azaline B on follicular development and functions in the hamster.

Prabuddha Chakraborty1, Shyamal K Roy2.   

Abstract

The usefulness of azaline B, a GnRH antagonist, in suppressing gonadotropin secretion in the golden hamster was examined by examining follicular development, steroidogenesis and expression of steroidogenic enzymes. Serum levels of P and E declined significantly, while FSH or LH was undetectable in azaline B-treated hamsters. FSH significantly increased serum E levels, whereas LH upregulated serum P levels. The formation of antral follicles ceased in azaline-treated hamsters, but was reversed by FSH with or without LH supplement. FSH also activated the primordial follicle pool resulting in increased formation of primary and preantral follicles. Further, an increasing trend in the formation of preantral follicles in response to E or E + P, and the formation of antral follicles in response to E + P treatment was evident. The level of Cyp11a1 mRNA increased markedly in LH- or LH + FSH-treated hamsters, whereas FSH with or without LH upregulated Cyp17a1, Cyp19a1 and Fshr mRNA expression. E without or with P also upregulated ovarian Cyp19a1 mRNA expression. The expression of enzyme protein corroborated the mRNA data. In summary, azaline B is an efficient GnRH antagonist in the hamster, and will be useful in studying the selective effect of gonadotropins on ovarian functions without disrupting the physiological functions of other hormones in ovarian cells.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Azaline B; FSH; Follicles; LH; Ovary

Mesh:

Substances:

Year:  2014        PMID: 25462584      PMCID: PMC4274241          DOI: 10.1016/j.mce.2014.11.011

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  63 in total

1.  The activity of 17alpha-hydroxylase/C17-C20 lyase in the ovaries of immature hypophysectomized rats treated with recombinant FSH combined with various doses of human chorionic gonadotropin.

Authors:  K Okuda; T Okazaki; M Saeki; H Mori
Journal:  Eur J Endocrinol       Date:  1997-11       Impact factor: 6.664

Review 2.  Hormonal control of gene expression in the ovary.

Authors:  J S Richards
Journal:  Endocr Rev       Date:  1994-12       Impact factor: 19.871

Review 3.  Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

Authors:  Anita H Payne; Dale B Hales
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

4.  Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.

Authors:  T R Kumar; Y Wang; N Lu; M M Matzuk
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

5.  Ovarian estrogen receptor alpha and beta mRNA expression: impact of development and estrogen.

Authors:  A E Drummond; A J Baillie; J K Findlay
Journal:  Mol Cell Endocrinol       Date:  1999-03-25       Impact factor: 4.102

6.  Direct effects of gonadotropin-releasing hormone on the ovary in rats and humans.

Authors:  T Uemura; T Namiki; A Kimura; T Yanagisawa; H Minaguchi
Journal:  Horm Res       Date:  1994

7.  Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".

Authors:  C A Campen; M T Lai; P Kraft; T Kirchner; A Phillips; D W Hahn; J Rivier
Journal:  Biochem Pharmacol       Date:  1995-05-11       Impact factor: 5.858

8.  Transforming growth factor-beta receptor type II expression in the hamster ovary: cellular site(s), biochemical properties, and hormonal regulation.

Authors:  S K Roy; A R Kole
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

9.  Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.

Authors:  A Dierich; M R Sairam; L Monaco; G M Fimia; A Gansmuller; M LeMeur; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.

Authors:  J E Rivier; G Jiang; J Porter; C A Hoeger; A G Craig; A Corrigan; W Vale; C L Rivier
Journal:  J Med Chem       Date:  1995-07-07       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.